NCT03038776View on ClinicalTrials.gov

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

November 30, 2017

Study Completion Date

May 31, 2019

Conditions
Influenza, Avian
Interventions
BIOLOGICAL

Recombinant influenza hemagglutinin

Avian H7N9 influenza vaccine

Trial Locations (1)

5042

Flinders University, Adelaide

All Listed Sponsors
collaborator

Australian Respiratory and Sleep Medicine Institute

OTHER

lead

Vaxine Pty Ltd

INDUSTRY

NCT03038776 - Recombinant H7 Hemagglutinin Influenza Vaccine Trial | Biotech Hunter | Biotech Hunter